Literature DB >> 26303068

Three-Dimensional Morphology by Multiphoton Microscopy with Clearing in a Model of Cisplatin-Induced CKD.

Richard Torres1, Heino Velazquez2, John J Chang2, Michael J Levene3, Gilbert Moeckel4, Gary V Desir2, Robert Safirstein5.   

Abstract

Traditional histologic methods are limited in their ability to detect pathologic changes of CKD, of which cisplatin therapy is an important cause. In addition, poor reproducibility of available methods has limited analysis of the role of fibrosis in CKD. Highly labor-intensive serial sectioning studies have demonstrated that three-dimensional perspective can reveal useful morphologic information on cisplatin-induced CKD. By applying the new technique of multiphoton microscopy (MPM) with clearing to a new mouse model of cisplatin-induced CKD, we obtained detailed morphologic and collagen reconstructions of millimeter-thick renal sections that provided new insights into pathophysiology. Quantitative analysis revealed that a major long-term cisplatin effect is reduction in the number of cuboidal cells of the glomerular capsule, a change we term the "uncapped glomerulus lesion." Glomerulotubular disconnection was confirmed, but connection remnants between damaged tubules and atubular glomeruli were observed. Reductions in normal glomerular capsules corresponded to reductions in GFR. Mild increases in collagen were noted, but the fibrosis was not spatially correlated with atubular glomeruli. Glomerular volume and number remained unaltered with cisplatin exposure, but cortical tubulointerstitial mass decreased. In conclusion, new observations were made possible by using clearing MPM, demonstrating the utility of this technique for studies of renal disease. This technique should prove valuable for further characterizing the evolution of CKD with cisplatin therapy and of other conditions.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  chronic renal failure; cisplatin nephrotoxicity; histopathology; pathology; renal microscopy; renal pathology

Mesh:

Substances:

Year:  2015        PMID: 26303068      PMCID: PMC4814184          DOI: 10.1681/ASN.2015010079

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  30 in total

1.  Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function.

Authors:  Paul C Grimm; Peter Nickerson; Jim Gough; Rachel McKenna; Elzbieta Stern; John Jeffery; David N Rush
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

2.  Long-term renal function after treatment for malignant germ-cell tumours.

Authors:  S D Fosså; N Aass; M Winderen; O P Börmer; D R Olsen
Journal:  Ann Oncol       Date:  2002-02       Impact factor: 32.976

Review 3.  Late toxicity following curative treatment of testicular cancer.

Authors:  C Kollmannsberger; M Kuzcyk; F Mayer; J T Hartmann; L Kanz; C Bokemeyer
Journal:  Semin Surg Oncol       Date:  1999-12

Review 4.  Nonimmunologic mechanisms of glomerular injury.

Authors:  J L Olson; R H Heptinstall
Journal:  Lab Invest       Date:  1988-11       Impact factor: 5.662

5.  Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy.

Authors:  Behzad Najafian; Youngki Kim; John T Crosson; Michael Mauer
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

6.  A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy.

Authors:  Wendy E Hoy; Rebecca N Douglas-Denton; Michael D Hughson; Alan Cass; Kelli Johnson; John F Bertram
Journal:  Kidney Int Suppl       Date:  2003-02       Impact factor: 10.545

Review 7.  Cisplatin nephrotoxicity.

Authors:  Istvan Arany; Robert L Safirstein
Journal:  Semin Nephrol       Date:  2003-09       Impact factor: 5.299

8.  Macrophage-specific deletion of transforming growth factor-β1 does not prevent renal fibrosis after severe ischemia-reperfusion or obstructive injury.

Authors:  Sarah C Huen; Gilbert W Moeckel; Lloyd G Cantley
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

9.  Met activation is required for early cytoprotection after ischemic kidney injury.

Authors:  Sherene Mason; Carlos Hader; Arnaud Marlier; Gilbert Moeckel; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

10.  Role of dynamin, synaptojanin, and endophilin in podocyte foot processes.

Authors:  Keita Soda; Daniel M Balkin; Shawn M Ferguson; Summer Paradise; Ira Milosevic; Silvia Giovedi; Laura Volpicelli-Daley; Xuefei Tian; Yumei Wu; Hong Ma; Sung Hyun Son; Rena Zheng; Gilbert Moeckel; Ottavio Cremona; Lawrence B Holzman; Pietro De Camilli; Shuta Ishibe
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

View more
  42 in total

1.  Cisplatin nephrotoxicity as a model of chronic kidney disease.

Authors:  Mingjun Shi; Kathryn L McMillan; Junxia Wu; Nancy Gillings; Brianna Flores; Orson W Moe; Ming Chang Hu
Journal:  Lab Invest       Date:  2018-06-01       Impact factor: 5.662

2.  FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury.

Authors:  Fanghua Li; Zhiwen Liu; Chengyuan Tang; Juan Cai; Zheng Dong
Journal:  FASEB J       Date:  2018-01-22       Impact factor: 5.191

3.  Combined Structural and Functional Imaging of the Kidney Reveals Major Axial Differences in Proximal Tubule Endocytosis.

Authors:  Claus D Schuh; Marcello Polesel; Evgenia Platonova; Dominik Haenni; Alkaly Gassama; Natsuko Tokonami; Susan Ghazi; Milica Bugarski; Olivier Devuyst; Urs Ziegler; Andrew M Hall
Journal:  J Am Soc Nephrol       Date:  2018-10-09       Impact factor: 10.121

4.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 5.  Rodent models of AKI-CKD transition.

Authors:  Ying Fu; Chengyuan Tang; Juan Cai; Guochun Chen; Dongshan Zhang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-27

Review 6.  Developing better mouse models to study cisplatin-induced kidney injury.

Authors:  Cierra N Sharp; Leah J Siskind
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-19

7.  A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors.

Authors:  Xiangdong Xue; Ruonan Bo; Haijing Qu; Bei Jia; Wenwu Xiao; Ye Yuan; Natalia Vapniarsky; Aaron Lindstrom; Hao Wu; Dalin Zhang; Longmeng Li; Marina Ricci; Zhao Ma; Zheng Zhu; Tzu-Yin Lin; Angelique Y Louie; Yuanpei Li
Journal:  Biomaterials       Date:  2020-07-15       Impact factor: 12.479

8.  Moderate aging does not exacerbate cisplatin-induced kidney injury or fibrosis despite altered inflammatory cytokine expression and immune cell infiltration.

Authors:  Cierra N Sharp; Mark Doll; Tess V Dupre; Levi J Beverly; Leah J Siskind
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-28

Review 9.  The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction.

Authors:  Robert L Chevalier
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

10.  C57BL/6 mice require a higher dose of cisplatin to induce renal fibrosis and CCL2 correlates with cisplatin-induced kidney injury.

Authors:  Sophia M Sears; Cierra N Sharp; Austin Krueger; Gabrielle B Oropilla; Douglas Saforo; Mark A Doll; Judit Megyesi; Levi J Beverly; Leah J Siskind
Journal:  Am J Physiol Renal Physiol       Date:  2020-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.